Monthly Updates - November 2022
Welcome 

Dear Colleague, 

Welcome to the November edition of the SOLVE-CHD monthly updates 2022. This monthly e-newsletter will keep you up to date with the key progress of the SOLVE-CHD projects and provide updates on our events and initiatives. Simply 
email solve-chd.info@sydney.edu.au if you wish to share/add anything from your area that is directly/indirectly related to the SOLVE-CHD program. We would also strongly encourage you to share your research highlights and successes that is relevant to cardiac rehabilitation and secondary prevention with us so that we can celebrate your achievements with our network. 

Key Updates and Research Highlights


  • SOLVE-CHD Postgraduate Scholarship applications at Deakin University and University of Sydney are open 

  • Welcome Dion Canderlaria to the team as a Post Doctoral Research Fellow working on the QUICR Study (MRFF funded project led by Prof Robyn Gallagher)

  • New guidelines from ICCPR provide guidance on how to deliver women-focused Cardiovacular Rehabilitation programming read more

  • Update your diary for 2023 NHMRC & MRFF grant opportunity dates - calendar is now available here 

A special congratulations goes out to the following SOLVE-CHD members:


If you have any research achievements that you'd like to highlight in the SOLVE-CHD newsletter, email us at solve-chd.info@sydney.edu.au
SOLVE-CHD Researcher Spotlight November
Prof Gemma A Figtree MBBS, DPhil (Oxon), FRACP, FCSANZ, FAHA
Professor in Medicine, University of Sydney
Interventional Cardiologist, Royal North Shore Hospital
Gemma is a Professor in Medicine and Chair of the multi-disciplinary Cardiovascular Initiative at the University of Sydney and an Interventional Cardiologist at Royal North Shore Hospital. She has an international track record across a diverse range of fundamental, translational and implementation research areas, and is recognised for her strategic leadership. 
Gemma is committed to preventing heart attacks through innovations to detect and treat silent coronary artery disease (CAD). She leads a diverse team unravelling key mechanisms underlying susceptibility and response to heart attack, with studies extending from the bench to large cohort studies and clinical trials. Discoveries in her Laboratory have been published in leading journals including the Lancet, Circulation, JACC and European Heart Journal, with > 220 publications. Gemma is a principal investigator on grants >$21 Mill. She has 1 awarded patent and 5 provisional patents and is the Chief Medical Officer for Prokardia. She is the lead investigator of CAD Frontiers, a NFP Venture that pulls together an international team of clinicians, researchers, healthcare, and industry leaders into an effective platform combining discovery science, clinical trials and commercial translation, with a vision of a world without heart attacks. 

Follow Gemma on Twitter @gemtree

SOLVE-CHD Postgraduate Scholarships are now open
$32,000 per annum (up to 3 years) for Postgraduate/HDR students to undertake research in cardiac rehabilitation and secondary prevention field.

Other Events and Opportunities 

ACHD Symposium 2022
Fabulous forum for sharing clinical advances and regional/international research complex cases & challenging diagnoses ACHD quality/outcome
ISHCA 23 - registrations and abstract submission now open 
ACRA ASM 2023 - SAVE THE DATE 
SOLVE-CHD will be supporting conference registration again - stay tuned!
Get your work ready for CSANZ & ANZET 2023 - abstract submission is now OPEN!

Connect with SOLVE-CHD on Social Media

Twitter LinkedIn

                                  Not a member yet? Scan me☝️to join now! 

Subscribe to our email list.